GnRH-a | Search

Trials

60 participants · First posted Oct 30, 2023

Completed

NCT01218581

Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis

32 participants · First posted Oct 11, 2010

Completed

NCT02496754

Follicular Long GnRH Agonist Versus Antagonist Protocol in PCOS Women Undergoing in Vitro Fertilization

1,266 participants · First posted Jul 14, 2015

Drugs

View all 5563 →

Small Molecule

Approved

Triptorelin(Decapeptyl, Trelstar, Triptodur)

Conditions: Advanced Prostate Cancer

C₆₄H₈₂N₁₈O₁₃ · Rx

Small Molecule

Approved

Degarelix(Firmagon, Degarelix Accord)

Conditions: Advanced Prostate Cancer

C₈₂H₁₀₃ClN₁₈O₁₆ · Rx

Small Molecule

Approved

Gonadorelin(Lutrepulse)

Manufacturer: Ferring pharmaceuticals inc, Baxter healthcare corp anesthesia critical care

C₅₅H₇₅N₁₇O₁₃ · Rx

Organizations

View all 4002 →

A&A SMALL CHANGES HANDYPEOPLE

United States

Novozymes A/S

Denmark

Ambu A/S

Denmark

News

View all 40731 →

2 years ago

GnRH-a Plus Letrozole or LNG-IUD Compared to Progesterone for Atypical Endometrial Hyperplasia

last year

Medicus Pharma to Acquire Antev for $75 Million, Gaining Novel GnRH Antagonist for Prostate Conditions

last year

Trials

GnRH-a on Angiogenesis of Endometriosis

Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis

Follicular Long GnRH Agonist Versus Antagonist Protocol in PCOS Women Undergoing in Vitro Fertilization

Drugs

Triptorelin(Decapeptyl, Trelstar, Triptodur)

Degarelix(Firmagon, Degarelix Accord)

Gonadorelin(Lutrepulse)

Organizations

A&A SMALL CHANGES HANDYPEOPLE

Novozymes A/S

Ambu A/S

News

GnRH-a Plus Letrozole or LNG-IUD Compared to Progesterone for Atypical Endometrial Hyperplasia

Medicus Pharma to Acquire Antev for $75 Million, Gaining Novel GnRH Antagonist for Prostate Conditions

Merigolix Shows Promise in Multiple Indications as TiumBio's Oral GnRH Antagonist Advances in Clinical Trials